S-allylcysteine prevents cisplatin-induced nephrotoxicity and oxidative stress

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 9, 2014, Pages 1271-1281

  Gõmez Sierra, Tania ^a   Molina Jijõn, Eduardo ^b   Tapia, Edilia ^c   Hernández Pando, Rogelio ^d   García Niño, Wylly Ramsés ^a   Maldonado, Perla D ^e   Reyes, José Luis ^b   Barrera Oviedo, Diana ^a   Torres, Ismael ^f   Pedraza Chaverri, José ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^f UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

cisplatin; nephrotoxicity; nuclear factor erythroid 2 related factor 2; oxidative stress; S allylcysteine

Indexed keywords

CATALASE; CISPLATIN; CREATININE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P47PHOX SUBUNIT; NITROGEN; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; S ALLYLCYSTEINE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; UREA; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CYBB PROTEIN, RAT; CYSTEINE; MEMBRANE PROTEIN; NEUTROPHIL CYTOSOLIC FACTOR 1; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; S-ALLYLCYSTEINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; KIDNEY CORTEX; KIDNEY DISTAL TUBULE; KIDNEY HOMOGENATE; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SINGLE DRUG DOSE; UREA NITROGEN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG EFFECTS; GARLIC; KIDNEY; KIDNEY DISEASES; METABOLISM; PHYTOTHERAPY; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CATALASE; CISPLATIN; CYSTEINE; GARLIC; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; KIDNEY; KIDNEY DISEASES; MALE; MALONDIALDEHYDE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN KINASE C BETA; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 84906240858     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12263     Document Type: Article

References (48)

1. Chirino Y, et al. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 2008; 245: 18-23.
2. Miller R, et al. Review article. Mechanisms of cisplatin nephrotoxicity. Toxins (Basel) 2010; 2: 2490-2518.
3. Dos Santos GN, et al. Review article. Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch Toxicol 2012; 86: 1233-1250.
4. Sancho-Martínez S, et al. Subcellular targets of cisplatin cytotoxicity: an integrated view. Pharmacol Ther 2012; 136: 35-55.
5. Pabla N, Dong Z,. Review. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008; 73: 994-1007.
6. Yao X, et al. Cisplatin nephrotoxicity: a review. Am J Med Sci 2007; 334: 115-124.
7. Chirino Y, Pedraza-Chaverri J,. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 2009; 61: 223-242.
8. Townsend D, et al. Metabolism of cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol 2003; 14: 1-10.
9. Wainford R, et al. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway. Toxicology 2008; 249: 184-193.
10. Barabas K, et al. Cisplatin: a review of toxicities and therapeutic applications. Vet Comp Oncol 2008; 6: 1-18.
11. Amagase H,. Clarifying the real bioactive constituents of garlic. J Nutr 2006; 136: 716S-725S.
12. Iciek M, et al. Review article. Biological properties of garlic and garlic-derived organosulfur compounds. Environ Mol Mutagen 2009; 50: 247-265.
13. Capasso A,. Antioxidant action and therapeutic efficacy of Allium sativum L. Molecules 2013; 18: 690-700.
14. Srinivasan K,. Antioxidant potential of spices and their active constituents. Crit Rev Food Sci Nutr 2014; 53: 352-372.
15. Queiroz Y, et al. Garlic (Allium sativum L.) and ready-to-eat garlic products: in vitro antioxidant activity. Food Chem 2009; 115: 371-374.
16. Herrera-Mundo N, et al. Antioxidant effect of S-allylcysteine, a garlic compound, in several experimental disease models. In:, Díaz-Muñoz M, Santamaría A, eds. Pro-oxidant reactions: Physiological and pathological implications. Kerala: Research Signpost, 2009: 67-84.
17. Colín-González A, et al. Review article. The antioxidant mechanism underlying the aged extract garlic-and S-allylcysteine-induced protection. Oxid Med Cell Longev 2009; 907: 162-178.
18. Numagami Y, Ohnishi STS,. S-Allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia. J Nutr 2011; 131: 1100S-1105S.
19. Maldonado P, et al. Role of allyl group in the hydroxyl and peroxyl radical scavenging activity of S-allylcysteine. J Phys Chem 2011; 115: 13408-13417.
20. Javed H, et al. S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res 2011; 1389: 133-142.
21. Saravanan G, Ponmurugan P,. Ameliorative potential of S-allyl cysteine on oxidative stress in STZ induced diabetic rats. Chem Biol Interact 2011; 189: 100-106.
22. Cruz C, et al. Renoprotective and antihypertensive effects of S-allylcysteine in 5/6 nephrectomized rats. Am J Physiol Renal Physiol 2007; 293: F1691-F1698.
23. Mong MC, Yin MC,. Nuclear factor κB-dependent anti-inflammatory effects of S-allylcysteine and S-propyl cysteine in kidney of diabetic mice. J Agric Food Chem 2012; 60: 3158-3165.
24. Kalayarasan S, et al. Chromium (VI)-induced oxidative stress and apoptosis is reduced by garlic and its derivative S-allylcysteine through the activation of Nrf2 in the hepatocytes of Wistar rats. J Appl Toxicol 2008; 28: 908-919.
25. Lowry O, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
26. Bradford M,. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
27. Molina-Jijõn E, et al. Deferoxamine pretreatment prevents Cr(VI)-induced nephrotoxicity and oxidant stress: role of Cr(VI) chelation. Toxicology 2011; 291: 93-101.
28. Chirino Y, et al. Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol Lett 2008; 176: 48-57.
29. Pedraza-Chaverri J, et al. Protective effects of garlic powder against potassium dichromate-induced oxidative stress and nephrotoxicity. Food Chem Toxicol 2008; 46: 619-627.
30. García-Niño WR, et al. Curcumin pretreatment prevents potassium dichromate-induced hepatotoxicity, oxidative stress, decreased respiratory complex I activity, and membrane permeability transition pore opening. Evid Based Complement Alternat Med 2013; 2013: 1-19.
31. 7-induced nephrotoxicity. BMC Nephrol 2005; 6: 4.
32. Pérez-Rojas J, et al. Renoprotection by α-mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity. Free Radic Res 2009; 43: 1122-1132.
33. Guerrero-Beltrán E, et al. Sulforaphane protects against cisplatin-induced nephrotoxicity. Toxicol Lett 2010; 176: 48-57.
34. Arreola-Mendoza L, et al. The protective effect of alpha-tocopherol against dichromate-induced renal tight junction damage is mediated via ERK1/2. Toxicol Lett 2009; 191: 278-288.
35. Vinay P, et al. Isolation of a pure suspension of rat proximal tubules. Am J Physiol Renal Physiol 1987; 241: F403-F411.
36. El-Naga R,. Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: impact on NOX-1, inflammation and apoptosis. Toxicol Appl Pharmacol 2013; 274: 87-95.
37. Lee H, et al. Protective role of phosphatidylcholine against cisplatin-induced renal toxicity and oxidative stress in rats. Food Chem Toxicol 2013; 58: 388-393.
38. Kodera Y, et al. Physical, chemical, and biological properties of S-Allylcysteine, an amino acid derived from garlic. J Agric Food Chem 2002; 50: 622-632.
39. Filomeni G, et al. Molecular transduction mechanism of the redox network underlying the antiproliferative effects of allyl compounds form garlic. J Nutr 2008; 138: 2053-2057.
40. Kröning R, et al. Differential effects of cisplatin in proximal and distal renal tubule epithelial cell lines. Br J Cancer 2000; 79: 293-299.
41. Van Angelen A, et al. Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice. Nephrol Dial Transplant 2013; 28: 879-889.
42. Konigsberg M., Radicales libres y estrés oxidativo. Aplicaciones médicas, 1st edn. Mexico City: Manual Moderno, 2008.
43. Deng B, et al. Inhibition of protein kinase C β2 prevents Tumor Necrosis Factor -α- induced apoptosis and oxidative stress in endothelial cells: the role of NADPH oxidase subunits. J Vasc Res 2011; 49: 144-159.
44. Gang G, et al. Protective role of NAD(P)H: quinone oxidorreductase 1 (NQO1) in cisplatin induced nephrotoxicity. Toxicol Lett 2013; 221: 165-175.
45. Wei X, et al. Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am J Physiol Renal Physiol 2008; 296: F427-F437.
46. Sahin K, et al. Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity. Biol Trace Elem Res 2014; 157: 156-163.
47. Coople I,. Review article. The Keap1-Nrf2 cell defense pathway-A promising therapeutic target. Adv Pharmacol 2012; 63: 43-77.
48. Bryan H, et al. The Nrf2 cell defense pathway: Keap1-dependent and -independent mechanisms of regulation. Biochem Pharmacol 2013; 85: 705-717.